Net Asset Value(s)

Finsbury Emerging Biotechnology Tst
08 September 2005


FINSBURY EMERGING BIOTECHNOLOGY TRUST PLC

NET ASSET VALUE

The estimated unaudited net asset value, calculated in accordance with the
guidelines of the Association of Investment Trust Companies, for Finsbury
Emerging Biotechnology Trust PLC at the close of business on 7 September 2005
was 117.25p (ex income).

The estimated NAV above includes the Company's interest in the Merlin Fund LP ('
Merlin'), which holds listed investments, cash and unlisted investments.  The
Company's pro rata share of unquoted securities in Merlin represents 3.9% of the
Company's estimated net asset value.  The pro rata share of the listed
securities and cash in Merlin represent 4.3% and 0.9% respectively of the
Company's estimated NAV.  The Company also holds unquoted securities
representing a further 2.9% of the Company's estimated net asset value.

For and on behalf of the Board

Close Finsbury Asset Management Limited

Secretary

8 September 2005

                      This information is provided by RNS
            The company news service from the London Stock Exchange